DK1370668T3 - Leporipox-baserede vektorvacciner - Google Patents
Leporipox-baserede vektorvaccinerInfo
- Publication number
- DK1370668T3 DK1370668T3 DK02732485T DK02732485T DK1370668T3 DK 1370668 T3 DK1370668 T3 DK 1370668T3 DK 02732485 T DK02732485 T DK 02732485T DK 02732485 T DK02732485 T DK 02732485T DK 1370668 T3 DK1370668 T3 DK 1370668T3
- Authority
- DK
- Denmark
- Prior art keywords
- virus
- lepori
- exogenous dna
- host
- recombinant leporipox
- Prior art date
Links
- 229940126580 vector vaccine Drugs 0.000 title abstract 2
- 241000700563 Leporipoxvirus Species 0.000 abstract 4
- 108091029865 Exogenous DNA Proteins 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 230000009851 immunogenic response Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01200869 | 2001-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1370668T3 true DK1370668T3 (da) | 2006-06-06 |
Family
ID=8179978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02732485T DK1370668T3 (da) | 2001-03-08 | 2002-03-07 | Leporipox-baserede vektorvacciner |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6942864B2 (de) |
| EP (1) | EP1370668B1 (de) |
| JP (1) | JP4037273B2 (de) |
| CN (1) | CN1258596C (de) |
| AT (1) | ATE318321T1 (de) |
| AU (1) | AU2002304856B2 (de) |
| BR (1) | BR0207761A (de) |
| CA (1) | CA2439872C (de) |
| DE (1) | DE60209345T2 (de) |
| DK (1) | DK1370668T3 (de) |
| ES (1) | ES2258628T3 (de) |
| MX (1) | MXPA03007862A (de) |
| NO (1) | NO331305B1 (de) |
| NZ (1) | NZ527940A (de) |
| PT (1) | PT1370668E (de) |
| WO (1) | WO2002072852A2 (de) |
| ZA (1) | ZA200306607B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2457584B1 (de) * | 2006-06-01 | 2017-08-09 | Robarts Research Institute | Myxomavirus-mutanten zur krebsbehandlung |
| KR100831537B1 (ko) * | 2007-01-19 | 2008-05-22 | 리엔 창 일렉트로닉 엔터프라이즈 컴퍼니 리미티드 | 하프 브릿지 드라이버 |
| KR100831536B1 (ko) * | 2007-01-19 | 2008-05-22 | 리엔 창 일렉트로닉 엔터프라이즈 컴퍼니 리미티드 | 풀 브릿지 드라이버 |
| FR2925067B1 (fr) * | 2007-12-18 | 2010-01-15 | Agronomique Inst Nat Rech | Vecteurs vaccinaux derives de leporipoxvirus |
| WO2021202971A1 (en) * | 2020-04-02 | 2021-10-07 | Arizona Board Of Regents On Behalf Of Arizona State University | Covid-19 vaccine based on the myxoma virus platform |
| CN111904981A (zh) * | 2020-09-07 | 2020-11-10 | 威世药业（如皋）有限公司 | 一种痘苗病毒致炎兔皮生产方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
| US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| US5505941A (en) * | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| DE10399032I1 (de) * | 1987-08-28 | 2004-01-29 | Health Research Inc | Rekombinante Viren. |
| AU2347692A (en) | 1991-07-09 | 1993-02-11 | Cornell Research Foundation Inc. | Recombinant viral vaccine |
| TW377373B (en) | 1993-09-22 | 1999-12-21 | Wyeth Corp | Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease |
| US6001349A (en) * | 1995-02-22 | 1999-12-14 | Therion Biologics Corporation | Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof |
| FR2736358B1 (fr) * | 1995-07-05 | 1997-09-26 | Agronomique Inst Nat Rech | Virus myxomateux recombinant |
| WO1998012311A2 (en) * | 1996-09-11 | 1998-03-26 | The General Hospital Corporation | Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| US6127172A (en) | 1998-05-29 | 2000-10-03 | University Of Florida | Materials and methods for delivery and expression of heterologous DNA in vertebrate cells |
| ES2153284B1 (es) | 1998-06-10 | 2001-09-01 | Fundacion Para El Estudio Y De | Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos. |
| US6294176B1 (en) * | 1998-07-10 | 2001-09-25 | Schering-Plough Veterinary Corp. | Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species |
-
2002
- 2002-03-07 AU AU2002304856A patent/AU2002304856B2/en not_active Ceased
- 2002-03-07 NZ NZ527940A patent/NZ527940A/en not_active IP Right Cessation
- 2002-03-07 EP EP02732485A patent/EP1370668B1/de not_active Expired - Lifetime
- 2002-03-07 WO PCT/EP2002/002858 patent/WO2002072852A2/en active IP Right Grant
- 2002-03-07 MX MXPA03007862A patent/MXPA03007862A/es active IP Right Grant
- 2002-03-07 PT PT02732485T patent/PT1370668E/pt unknown
- 2002-03-07 ES ES02732485T patent/ES2258628T3/es not_active Expired - Lifetime
- 2002-03-07 AT AT02732485T patent/ATE318321T1/de not_active IP Right Cessation
- 2002-03-07 CN CN02806102.0A patent/CN1258596C/zh not_active Expired - Fee Related
- 2002-03-07 BR BR0207761-2A patent/BR0207761A/pt not_active IP Right Cessation
- 2002-03-07 DK DK02732485T patent/DK1370668T3/da active
- 2002-03-07 CA CA002439872A patent/CA2439872C/en not_active Expired - Fee Related
- 2002-03-07 US US10/471,300 patent/US6942864B2/en not_active Expired - Fee Related
- 2002-03-07 DE DE60209345T patent/DE60209345T2/de not_active Expired - Lifetime
- 2002-03-07 JP JP2002571903A patent/JP4037273B2/ja not_active Expired - Fee Related
-
2003
- 2003-08-25 ZA ZA2003/06607A patent/ZA200306607B/en unknown
- 2003-09-04 NO NO20033912A patent/NO331305B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20040137599A1 (en) | 2004-07-15 |
| CA2439872A1 (en) | 2002-09-19 |
| CN1527883A (zh) | 2004-09-08 |
| DE60209345T2 (de) | 2006-08-03 |
| MXPA03007862A (es) | 2004-05-24 |
| PT1370668E (pt) | 2006-06-30 |
| NO20033912D0 (no) | 2003-09-04 |
| JP4037273B2 (ja) | 2008-01-23 |
| NZ527940A (en) | 2005-01-28 |
| EP1370668A2 (de) | 2003-12-17 |
| BR0207761A (pt) | 2006-01-31 |
| ZA200306607B (en) | 2005-02-23 |
| US6942864B2 (en) | 2005-09-13 |
| WO2002072852A3 (en) | 2002-12-27 |
| CN1258596C (zh) | 2006-06-07 |
| EP1370668B1 (de) | 2006-02-22 |
| DE60209345D1 (de) | 2006-04-27 |
| CA2439872C (en) | 2009-12-15 |
| NO331305B1 (no) | 2011-11-21 |
| ATE318321T1 (de) | 2006-03-15 |
| JP2004528833A (ja) | 2004-09-24 |
| WO2002072852A2 (en) | 2002-09-19 |
| ES2258628T3 (es) | 2006-09-01 |
| AU2002304856B2 (en) | 2006-08-24 |
| NO20033912L (no) | 2003-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900180A1 (ru) | Рекомбинантный модифицированный вирус осповакцины анкара (mva), экспрессирующий гомологичные последовательности, встроенные в поксвирусный геном | |
| ATE447967T1 (de) | Verpackung von immunstimulierendem cpg in virusähnlichen partikeln: herstellungsverfahren und verwendung | |
| FI931309A0 (fi) | Viralt bristfaelligt vaccin, som har producerats med en transkomplementerande cellinie | |
| WO2008039408A3 (en) | Live bacterial vaccines for viral infection prophylaxis or treatment | |
| CY1112749T1 (el) | Εμβολια διεγερσης/αναμνησης κατα της ελονοσιας | |
| MX2022010588A (es) | Vacuna basada en poxvirus recombinantes contra el virus sars-cov-2. | |
| WO2001091536A3 (en) | Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens | |
| NZ627888A (en) | Materials and methods for respiratory disease control in canines | |
| EA201071366A1 (ru) | Комбинированная вакцина против кори и вируса папилломы человека | |
| WO2007008918A3 (en) | Virus vaccines comprising envelope-bound immunomodulatory proteins and methods of use thereof | |
| DE50206472D1 (de) | Attenuierte lebendimpfstoffe | |
| BRPI0816134A2 (pt) | Herpesvírus, sequência de dna, vetor, célula, vírus, método para produção de partículas infecciosas, partículas infecciosas, vacina, uso de herpesvírus ou da sequência de dna ou do vetor ou das partículas infecciosas, e, método para o tratamento preventivo e/ou terapêutico de uma doença. | |
| AR094725A1 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
| ZA201707985B (en) | Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine | |
| MX2020012913A (es) | Proteinas de consenso para el virus de la enfermedad de la fiebre aftosa (fmdv), secuencias de codificacion para estas y vacunas elaboradas a partir de estas. | |
| Hajam et al. | Co-administration of flagellin augments immune responses to inactivated foot-and-mouth disease virus (FMDV) antigen | |
| ES2608627T5 (es) | Uso de un poxvirus modificado para inducción rápida de inmunidad frente a un poxvirus u otros agentes infecciosos | |
| BRPI0512421A (pt) | recombinantes de avipox expressando genes do vìrus da doença febre aftosa | |
| DK1370668T3 (da) | Leporipox-baserede vektorvacciner | |
| TW200734463A (en) | Marked bovine viral diarrhea virus vaccines | |
| PH12017501100B1 (en) | Recombinant swinepox virus and vaccines | |
| WO2004009763A3 (en) | Use of vaccinia virus deleted for the e3l gene as a vaccine vector | |
| WO2003080112A3 (en) | Imidazoquinolineamines as adjuvants in hiv dna vaccination | |
| WO2006113927A3 (en) | Immunogenic vaccinia peptides and methods of using same | |
| WO2019113285A3 (en) | Zika vaccines and methods of use |